Pierre Plante

Les Produits Chimiques Delmar, Inc. manufactures and markets active pharmaceutical ingredients. Its manufacturing capabilities include lab scale, pilot plant, and multi-ton production. The firm's services include process development and validation, analytical method development, stability studies according to ICH guidelines, custom synthesis from grams to multi-tons, peptide synthesis, technology transfer, complete regulatory documentation including DMF submissions, and patent applications. The company was founded in 1941 and is headquartered in LaSalle, Canada.

PurCann Pharma, Inc. produces purified cannabinoids derived from Canadian biomass. The private company is based in Canada and has subsidiaries in the country. The Canadian company offers these cannabinoids as bulk or packaged products, including tinctures, sprays, and softgels.

Les Produits Chimiques Delmar, Inc. manufactures and markets active pharmaceutical ingredients. Its manufacturing capabilities include lab scale, pilot plant, and multi-ton production. The firm's services include process development and validation, analytical method development, stability studies according to ICH guidelines, custom synthesis from grams to multi-tons, peptide synthesis, technology transfer, complete regulatory documentation including DMF submissions, and patent applications. The company was founded in 1941 and is headquartered in LaSalle, Canada.

Les Produits Chimiques Delmar, Inc. manufactures and markets active pharmaceutical ingredients. Its manufacturing capabilities include lab scale, pilot plant, and multi-ton production. The firm's services include process development and validation, analytical method development, stability studies according to ICH guidelines, custom synthesis from grams to multi-tons, peptide synthesis, technology transfer, complete regulatory documentation including DMF submissions, and patent applications. The company was founded in 1941 and is headquartered in LaSalle, Canada.

Les Produits Chimiques Delmar, Inc. manufactures and markets active pharmaceutical ingredients. Its manufacturing capabilities include lab scale, pilot plant, and multi-ton production. The firm's services include process development and validation, analytical method development, stability studies according to ICH guidelines, custom synthesis from grams to multi-tons, peptide synthesis, technology transfer, complete regulatory documentation including DMF submissions, and patent applications. The company was founded in 1941 and is headquartered in LaSalle, Canada.